Capel Thompson & Homer LLP (Health Sciences Transactional Advisory)

“CTH” is a UK/US based specialist biosciences Transactional Advisory firm, providing the following services: In- and Out-Licensing and Alliances; Project Acquisitions and Divestitures; M&A; and Equity Private Placements.

CTH Key Competencies include: Financial Analysis; Commercial and Technical Due Diligence; and Transaction Initiation, Valuation and Negotiation.

Activity:

- Licensing & Business Development
- Other Industry Services

Product / Technology type(s) covered:

Therapeutic targets:

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active: Europe , North America

c. Countries active: USA, Canada, UK, Germany, France etc.

Corporate data:

Number of Employees: 6

Turnover:

Amount:	Year:	Currency:
-	2002	Euro

Year founded: 2002

Partners / Alliances: "CTH" is an affiliate of the Ferghana Partners Group (“FPG”), a full service Life Sciences Investment Bank with offices in New York City and London.

Our US Partner company is Healthcare Venture Associates, Inc ("HVA")of New Jersey.